TBE booster immunization according to the rapid immunization schedule: Are 3-year booster intervals really necessary?

Vaccine

Volumn 23, Issue 3, 2004, Pages 312-315

  Zent, Olaf ^a   Plentz, Annelie ^b   Schwarz, Tino F ^c   Frühwein, Nikolaus ^d   Kuhr, Hans B ^e   Broeker, Michael ^a   Banzhoff, Angelika ^a   Jilg, Wolfgang ^b  

^a Chiron Vaccines   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Stiftung Juliusspital   (Germany)

^d Practice   (Germany)

^e Practice   (Germany)

Author keywords

Immunogenicity; Safety; Tick borne encephalitis; Vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; TICK BORNE ENCEPHALITIS VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; FOLLOW UP; HUMAN; IMMUNIZATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEROLOGY; TICK BORNE ENCEPHALITIS; TIME SERIES ANALYSIS;

ADULT; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FEMALE; HUMANS; IMMUNITY, NATURAL; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; TIME FACTORS; VACCINATION; VIRAL VACCINES;

EID: 7744220519     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.007     Document Type: Article

References (11)

1. P.N. Barret, F. Dorner, and S.A. Plotkin Tick-borne encephalitis vaccine S.A. Plotkin W.A. Orenstein Vaccines 1999 W.B. Saunders Company Philadelphia 767 781
2. O. Zent, W. Jilg, A. Plentz, T.F. Schwarz, N. Frühwein, and H.B. Kuhr Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule Vaccine 21 2003 4655 4660
3. I. Harabacz, H. Bock, Jüngst Ch., U. Klockmann, M. Praus, and R. Weber A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimen Vaccine 10 1992 145 150
4. R. Kaiser, D. Neumann-Haefelin, J. Hartmann, and W.A. Stunder Impfung gegen FSME: Wie lange hält der Impfschutz und was bringt die Antikörperbestimmung zur Überprüfung der Immunitätslage? Z. Allg. Med. 75 1999 373 374
5. R. Kaiser Impfung gegen FSME - Fraglicher Nutzen der Antikö rperbestimmung zur Überprüfung der Immunitätslage Deut. Med. Wschr. 124 1999 542
6. C. Kunz Epidemiology of tick-borne encephalitis and the impact of vaccination on the incidence of disease M.M. Eible C. Huber H.H. Peter V. Wahn Proceedings of the Vth Symposium on Immunology 1996 Springer Berlin 143 149
7. ® adults. Version of November 2003. Chiron Behring GmbH & Co. KG.
8. O. Zent, J. Beran, W. Jilg, T. Mach, and A. Banzhoff Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults Vaccine 21 2003 738 741
9. Rendi-Wagner P, Kundi M, Zent O, Dvorak G, Jaehnig P, Holzmann H, et al. Protective immunity following vaccination against tick-borne-encephalitis: antibody persistence longer than expected? Vaccine 2004;22:2743-9.
10. J. Beran, R. Chlibek, P. Douda, D. Gniel, and Zent O Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule Int. J. Med. Microbiol. 37 Suppl 2004 130 133
11. Anonymous. Impfplan 2004 Österreich. Empfehlungen des Obersten Sanitätsrates (Impfausschuss) vom 4. November 2003; http://www.bmgf.gv.at.